000			05589cam a2200457M 4500
988			_aSpringer_Medicine_2017
999			_c96480 _d96480 _x1
001			96480
003			ES-MaUEC
005			20230102112756.0
006			m o d
007			cr |n|||||||||
008			170906s2017 sz o 000 0 eng d
020			_a3319547267 _q(electronic bk.)
020			_a9783319547268 _q(electronic bk.)
020			_z3319547259
020			_z9783319547251
040			_aYDX _beng _cYDX _dN$T _dEBLCP _dGW5XE _dN$T _dOCLCF _dAZU _dUPM _dMERER _dIOG _dCOO _dOCLCO _dOCLCQ _dOCLCA _dES-MaUEC _bspa
050		4	_aRJ496.H3 _b2017 EB
245	0	0	_aHeadache and comorbidities in childhood and adolescence _cVincenzo Guidetti, Marco A. Arruda, Aynur Ozge, editors.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
490	0		_aHeadache
500			_a
505	0		_aForeword; Preface; References; Contents; Contributors; Chapter 1: Epidemiology of Headache in Children and Adolescents; 1.1 Introduction; 1.2 Magnitude of Headache Syndromes Among Children and Adolescents in the General Population; 1.3 Risk Factors and Correlates; 1.4 Incidence and Course of Disease; 1.5 Impact of Migraine; References; Chapter 2: Classification and Limits; References; Chapter 3: Migraine Genetics; 3.1 Introduction; 3.2 Syndromic Forms; 3.2.1 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
505	8		_a3.2.2 Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)3.2.3 Retinal Vasculopathy and Cerebral Leukodystrophy (RVCL); 3.2.4 COL4A1-Related Syndromes; 3.2.5 Familial Anticipated Sleep Phase Syndrome (FASPS); 3.3 Monogenic Forms of Migraine; 3.4 Polygenic Forms; 3.4.1 Genome-Wide Association Studies (GWAS); 3.5 Conclusions; References; Chapter 4: Epigenetics; 4.1 Introduction; 4.2 Basic Mechanisms of Epigenetics; 4.3 Epigenetic Mechanisms in Migraine and Headache; 4.4 Epigenetics, Environmental Factors, and Comorbidities; 4.5 Conclusion; References
505	8		_a6.4 Mechanisms Linking Maltreatment and Headache6.5 Management in Children with Maltreatment and Headaches; 6.6 Conclusion; References; Chapter 7: Childhood Episodic Syndromes That May Be Associated with Migraine; 7.1 Background; 7.2 Classification and Current State of Clinical Practice in Episodic Syndromes That May Be Associated with Migraine; 7.2.1 Cyclic Vomiting Syndrome (ICHD-III Beta 1.6.1.1); 7.2.2 Abdominal Migraine (ICHD-III Beta 1.6.1.2); 7.2.3 Benign Paroxysmal Vertigo of Childhood (ICHD-III Beta 1.6.2); 7.2.4 Benign Paroxysmal Torticollis of Infancy (ICHD-III Beta 1.6.3)
505	8		_a7.2.5 Infant Colic (ICHD-III Beta A1.6.4)7.2.6 Alternating Hemiplegia of Childhood (AHC) (ICHD-III Beta A1.6.5); 7.2.7 Vestibular Migraine (ICHD-III Beta A1.6.6); 7.3 Pathogenetic Hypothesis, Treatment and Remaining Concerns in Episodic Syndromes; References; Chapter 8: Comorbidity with Attention Deficit Hyperactivity Disorder; 8.1 Background; 8.2 ADHD Diagnosis and Prevalence; 8.3 Migraine and ADHD: Clinical Studies; 8.4 Migraine and ADHD: Populational Studies; 8.5 Zoom In; 8.6 Ongoing Work; 8.7 Treatment; 8.8 Conclusion; References
505	8		_aChapter 5: Headache, Burden, and Quality of Life5.1 Introduction; 5.2 Burden of Pediatric Headache; 5.3 Quality of Life and Pediatric Headache; 5.4 Clinical Implications; References; Chapter 6: Child Abuse and Headache in Children and Adolescents; 6.1 Introduction; 6.2 Prevalence of Childhood Maltreatment in Headache Disorders; 6.3 Effects of Childhood Maltreatment on Brain Development; 6.3.1 Structural and Functional Changes; 6.3.2 Effects on Cognitive and Neuropsychology Development; 6.3.2.1 Language; 6.3.2.2 Attention and Executive Function; 6.3.2.3 Memory and Learning
520	3		_aThis book aims to provide clinicians and other practitioners and professionals with up-to-date information on how to evaluate and manage headaches in children and adolescents, highlighting the most recent recommendations. Unlike in other books on the subject, detailed attention is devoted to the various comorbidities commonly associated with headache, including psychiatric comorbidities such as depression, anxiety, attention deficit hyperactivity disorder, and learning disabilities and medical conditions such as epilepsy, vascular disorders, brain tumors, atopic disease, and obesity. The intimate link between these conditions and headache is explained with a view to enabling the reader to recognize their presence and, on that basis, to institute the most effective pharmacological or non-pharmacological treatment strategy. Moreover, knowledge of the comorbidities associated with headache will help readers to understand more fully the causes of this serious disorder and also its consequences, e.g., for school performance, relationships, and daily activities. The authors are all international experts who care for children with headache or the other described disorders.
650		7	_aCefalalgia en niños _2embne _9677525
700	1		_aArruda, Marco A.
700	1		_aGuidetti, Vincenzo.
700	1		_aOzge, Aynur. _998471
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-54726-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI